D. G. Duda

A study reveals potential benefits of anti-miR-155 for NSCLC patients.

2025-08-22T01:31:30+00:00 ― 5 min read

Research reveals complexities in treating biliary tract cancers and immune interactions.

2025-06-05T06:30:30+00:00 ― 6 min read